Healthcare >> CEO Interviews >> April 29, 2025

Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)

Aminov, Erez
Erez Aminov is the Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc., a biopharmaceutical company developing treatments for neuropsychiatric disorders. In addition, Mr. Aminov serves as the Chairman and Chief Executive Officer of Telomir Pharmaceuticals, Inc., a biotechnology company dedicated to treating age-related inflammatory and degenerative conditions. Mr. Aminov also founded Locate Venture Corp, where he supported early-stage biotech enterprises and fostered growth through strategic partnerships. He has also served as a trusted consultant for multiple biotech firms and successfully guided two companies through IPOs on the Nasdaq. Mr. Aminov holds a bachelor of arts in Accounting from Touro University in New York. Profile
Word count: 1,967

TWST: Let’s begin with an overview of Mira Pharmaceuticals.

Mr. Aminov: Mira Pharmaceuticals is a